Subscribe to RoboticOncology.com RSS Feed

Metformin Double Duty: Diabetes and Prostate Cancer

New York, NY, Aug. 27, 2013 (GLOBE NEWSWIRE) -- Researchers in Canada share promising news for men with type 2 diabetes and prostate cancer. Long-term use of metformin for blood sugar control may also reduce the risk of prostate cancer death. For every six months of cumulative metformin treatment after prostate cancer diagnosis, risk of death dropped 24 percent. Sold under the brand names Glucophage, Glumetza, Riomet, and Fortamet, metformin is commonly prescribed to those with type 2 diabetes, sometimes in conjunction with insulin.

Dr. David Samadi, Chairman of Urology, Chief of Robotic Surgery at Lenox Hill Hospital and Professor of Urology at Hofstra North Shore-LIJ School of Medicine, believes these crossover findings could be very meaningful given the prevalence of both diseases, particularly in older men. However, more research is needed before metformin is added to the list of prostate cancer treatments, which includes robotic prostate surgery and radiation for prostate cancer.

The metformin results are based on a review of the medical records of Canadian men with both diabetes and prostate cancer. In observation of nearly 4,000 men, all age 67 or older, a strong link was discovered between long-term use of metformin and a lower risk of prostate cancer death. Interestingly, all-cause mortality also declined after six months of metformin treatment.

Findings appear in the Journal of Clinical Oncology, August 5, http://jco.ascopubs.org/content/early/2013/08/05/JCO.2012.46.7043.abstract

"The compounding impact of metformin on prostate cancer-specific mortality appears significant," said Dr. Samadi. "When a drug has a long track record of success with one disease, it's in our best interest to explore how it might benefit those with other conditions, as well. As we learn more, we may see metformin as a future adjunct therapy for prostate cancer."

As an affordable, safe, and well-tolerated medication, metformin is widely used and regarded in the treatment of type 2 diabetes. The long-term dose-response association with prostate cancer was only seen among the one-third of men taking a standard metformin dosage, not the remaining two-thirds using other forms of diabetes treatment.

While the findings do not indicate that metformin use prevents prostate cancer in any way, they do provide a promising foundation for further exploration. Researchers intend to study the use of metformin in prostate cancer patients, independent of type 2 diabetes, using large-scale, randomized trials.

For now, researchers concluded that metformin should continue to be used as a first-line type-2 diabetes treatment, particularly in men who also have prostate cancer.

Dr. David Samadi leads a diverse team of prostate cancer experts at the Lenox Hill Hospital Prostate Cancer Center in New York.

Back to Press Releases


Bookmark Using:
Facebook Twitter LinkedIn Email Yahoo

Share on Facebook

Call to Make an Appointment With Dr. David Samadi:

1-212-365-5000

Click the contact link to learn how Dr. Samadi can help treat your prostate cancer and give you back your quality of life.

* The benefits of robotic surgery cannot be guaranteed as surgery is both patient and procedure specific. Previous surgical results do not guarantee future outcomes.




Testimonials
S. Davis, USA

Dr. Samadi’s team from check-in to check-out was superlative.  And Dr. Samadi’s record of personally conducted robotic procedures and success rates are beyond compare.

more..
Yossi, Israel

I chose to undergo the operation with a specialist in the U.S., who has an extensive experience in robotic surgeries: Dr. David Smadi. The surgery was relatively simple: i didn't suffer any pain, lost a small amount of blood and had the catheter only for seven days. I got back to full functioning very soon afterwards.

more..
Little Johnny Rivero, Puerto Rico

PROSTATE CANCER! How could it be? I'm young and have had annual PSA tests to monitor my prostate cancer risk. I only recently began to experience sharp pain in my lower back but I knew I had to seek treatment.

more..
Alex W, Israel

The surgery was a lifesaver for my wife. Out of hospital in 24 hours, lost the catheter after six days. I was uncomfortable for a few days, but was dry at night after a week! Don't even think about it anymore. 6 weeks post surgery my PSA is 00!! I got my life and my life quality back!

more..